Netarsudil 0.02% / Latanoprost 0.005% fixed-dose combination
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Netarsudil 0.02% / Latanoprost 0.005% fixed-dose combination, covering 2025-11-18 to 2025-11-18. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanoprost 0.005% to Treat Glaucoma [Phase 4]